Neuregulin 1 (NRG-1) and its receptor ErbB4 have emerged as biologically plausible schizophrenia risk factors, modulators of GABAergic and dopaminergic neurotransmission, and as potent regulators of glutamatergic synaptic plasticity. NRG-1 acutely depotentiates LTP in hippocampal slices, and blocking ErbB kinase activity inhibits LTP reversal by theta-pulse stimuli (TPS), an activity-dependent reversal paradigm. NRG-1/ErbB4 signaling in parvalbumin (PV) interneurons has been implicated in inhibitory transmission onto pyramidal neurons. However, the role of ErbB4, in particular in PV interneurons, for LTP reversal has not been investigated. Here we show that ErbB4-null (ErbB4
Introduction
Maintaining the balance between excitation and inhibition is important for the homeostatic control of normal brain function and behavior, and imbalances are believed to contribute to the pathology of multiple psychiatric disorders, including schizophrenia (Benes and Berretta, 2001; Coyle, 2006; Kehrer et al., 2008; Lisman et al., 2008) . Recent rodent work from several laboratories suggests that the schizophrenia risk genes Neuregulin 1 (NRG-1) and ERBB4 may play an important role in regulating hippocampal and frontal cortical pyramidal neurons (for review, see Mei and Xiong, 2008; Buonanno, 2010) , while disrupted NRG-1/ErbB4 signaling perturbs neuronal network activity (Fisahn et al., 2009; Nason et al., 2011) , consistent with the notion of schizophrenia representing a disorder of functional connectivity and synaptic plasticity (Stephan et al., 2006) .
Acutely administered NRG-1 peptide blocks or reverses LTP at Schaeffer collateral-to-CA1 (SC3 CA1) glutamatergic synapses in the hippocampus (Huang et al., 2000; Kwon et al., 2005; Bjarnadottir et al., 2007) . Conversely, pharmacological blockade of ErbB receptor activity prevents LTP reversal by theta-pulse stimuli (TPS), which model a naturally occurring neural activity pattern in the hippocampus (Stäubli and Chun, 1996) , suggesting that neural activity recruits the NRG/ErbB pathway to antagonize synapse strengthening (Kwon et al., 2005) . While ErbB4, the main neuronal NRG receptor, is expressed in several interneuron subtypes in the cerebral cortex, it is not detected in pyramidal neurons (Vullhorst et al., 2009; Neddens and Buonanno, 2010; Neddens et al., 2011) , indicating that NRG/ErbB effects on synaptic plasticity are mediated via local circuit mechanisms.
Parvalbumin (PV)-expressing fast-spiking basket cells are especially relevant for the possible involvement of NRG-1/ErbB4 signaling in psychiatric disorders because (1) most PV interneurons in the prefrontal cortex (PFC) and many in the hippocampus coexpress ErbB4 (Fisahn et al., 2009; Fazzari et al., 2010; Neddens and Buonanno, 2010) ; (2) they are involved in gamma oscillations that are regulated by NRG-1/ErbB4 signaling and abnormal in schizophrenia (Kwon et al., 1999; Wilson et al., 2008; Fisahn et al., 2009); and (3) their number is reduced in the hippocampus of ErbB4 mutant mice (Neddens and Buonanno, 2010) , consistent with the reduced number of PV-expressing neurons in the PFC of individuals with schizophrenia (for review, see Lewis et al., 2005) . However, while ErbB4 expression in the neocortex and hippocampus appears tightly correlated with interneurons, outside the cerebral cortex, ErbB4 is expressed in other neuron types as well (Steiner et al., 1999; Gerecke et al., 2001; Fox and Kornblum, 2005) .
Here we analyzed LTP and LTP reversal at hippocampal SC¡CA1 synapses in ErbB4 Ϫ/Ϫ , PV-Cre;ErbB4, and NRG-1 hypomorphic mice. We also compared ErbB4 Ϫ/Ϫ and PV-Cre; ErbB4 mice in a battery of behavioral tests pertinent to schizophrenia and anxiety/fear. Our results unequivocally establish the requirement of ErbB4 signaling in PV interneurons for mediating NRG's effects on synaptic plasticity, and suggest that while ErbB4 activity in PV interneurons is important for behaviors associated with exploratory activity and sensorimotor gating, NRG/ErbB4 effects on other neural populations contribute to the regulation of anxiety and fear-related behaviors.
Materials and Methods

Animals
Full and conditional Erbb4 knock-out alleles have been described previously (Gassmann et al., 1995; Golub et al., 2004) . Both ErbB4 alleles target the second coding exon, removal of which destabilizes RNA and leads to the complete loss of detectable ErbB4 protein by Western blotting and immunofluorescence histology (Vullhorst et al., 2009) . Full ErbB4 mutant mice were rescued from embryonic lethality by transgenic ErbB4 overexpression in the heart (ErbB4 MHC-ErbB4 ) (Tidcombe et al., 2003) . ErbB4 MHC-ErbB4 mice were backcrossed to C57BL/6J mice for Ͼ15 generations. In our facility, ErbB4 lox mice were backcrossed for three generations to C57BL/6J and then maintained by inbreeding. NRG-1 hypomorphic mice harbored a targeted deletion in the EGF domain (NRG1 ⌬EGFϩ/Ϫ ), and were backcrossed to C57BL/6J mice for Ͼ15 generations (Erickson et al., 1997) . The PV-Cre mouse line Pva1b tm1(cre)Arbr , expressing Cre recombinase from the Pva1b locus by insertion of the gene into its 3Ј untranslated region, was obtained from The Jackson Laboratory (Hippenmeyer et al., 2005) . PV-Cre mice were on a mixed 129ϫC57BL/6J background, backcrossed in our facility for two generations to C57BL/6J and maintained as inbreds from then on. ErbB4-2A-Cre-ERT2 mice were provided by Dr. Hongkui Zeng (Allen Institute for Brain Science, Seattle, WA), and mice expressing tdTomato from the Rosa26 locus (Ai14) were obtained from The Jackson Laboratory (Madisen et al., 2010) . For more details on the generation and expression properties of ErbB4-Cre-ERT2 mice, please go to http://transgenicmouse. alleninstitute.org. Adult ErbB4-2A-CreERT2 ϫ Ai14 mice were injected intraperitoneally for 5 consecutive days with 1 mg of tamoxifen (Sigma). All mice were maintained under a 12/12 h light/dark cycle and received food ad libitum. Animal procedures were reviewed and approved by the NIH Animal Care and Use Committee.
Reagents
The NRG-1␤ 1 peptide (R&D Systems) encompasses the EGF-like domain between amino acids 176 -246, which is necessary and sufficient to activate the ErbB signaling pathway (Buonanno and Fischbach, 2001) . The NRG-1␤ 1 peptide was used because, in contrast to the entire extracellular domain, it penetrates the tissue and effectively activates ErbB receptors, as previously demonstrated (Kwon et al., 2005) . PD158780 was from Calbiochem and was reconstituted in DMSO at a stock concentration of 10 mM. Mouse monoclonal anti-parvalbumin antibody (clone PARV-19) was from Sigma. Rabbit monoclonal antibody mAB10 against ErbB4 has been described previously (Vullhorst et al., 2009) . A mouse monoclonal antibody against clathrin heavy chain (clone TD.1) was from Santa Cruz Biotechnology.
Protein extraction and Western blotting
Whole tissue lysates were generated from PV-Cre;ErbB4 f/f and ErbB4 f/f mice by sonication in 8 M urea/1% SDS. Proteins were reduced with 5 mM tributylphosphine (Sigma) and alkylated with 15 mM iodoacetamide (Sigma). Sixty micrograms of protein were size-fractionated on 4 -12% acrylamide/Tris-glycine gels (Invitrogen) and electrophoretically transferred onto nitrocellulose membranes. Excess binding capacities were blocked with 5% nonfat dry milk in Tris-buffered saline (137 mM NaCl, 3 mM KCl, 25 mM Tris-HCl, pH 7.4) containing 0.1% Tween 20 (TBS-T).
Membranes were probed sequentially with anti-ErbB4 (mAB10; 1 g/ ml) and mouse monoclonal antibody against clathrin heavy chain (0.03 g/ml) in 3% bovine serum albumin (BSA) in TBS-T. Antibody binding was visualized with secondary antibodies conjugated to horseradish peroxidase using enhanced chemiluminescence (GE Healthcare).
Electrophysiology
Transverse slices (300 -350 m) from the dorsal hippocampus were transferred to a submerged recording chamber continuously perfused at 2 ml/min (30°C) with ACSF containing the following (in mM): 125 NaCl, 26 NaHCO 3 , 2. For the induction of LTP, a general pairing protocol was used, composed of 100 pulses at 2 Hz and a holding potential of Ϫ10 -0 mV, as previously described (Kim and Lisman, 1999; Kwon et al., 2008) . Slices showing Ͻ130% LTP were excluded from analyses. Depotentiation was elicited by TPS (5 Hz, 1 min), as described by Stäubli and Chun (1996) . Picrotoxin (100 M) was included in some experiments. Recorded data were filtered at 3 kHz, sampled at 10 kHz using pClamp, and analyzed with Clampfit (Molecular Devices).
Results are presented as mean Ϯ SEM and analyzed for statistical significance using the Wilcoxon signed-rank test.
Immunofluorescence histology
Mice were transcardially perfused with 4% PFA in 0.1 M PBS, pH 7.4. Brains were postfixed overnight in the same fixative and 50 m sections were cut on a vibratome and saved for up to 3 weeks in 0.1 M PBS with sodium azide at ϩ4°C. Sections were blocked in 20% normal goat serum (NGS), 1% BSA, 0.25% Triton X-100 in 0.1 M PBS for 1 h at room temperature (RT) and incubated with anti-PV primary antibody (1: 6000) and/or rabbit monoclonal antibody mAB10 against ErbB4 (1 g/ ml) in 0.1 M PBS with 2% NGS and 0.25% Triton X-100 (dilution buffer) for 24 h at ϩ4°C with gentle rocking. Slices were washed in 0.1 M PBS with 0.25% Triton X-100 for at least 30 min before incubation with goat-antimouse Alexa 647 and/or anti-rabbit Alexa 594 secondary antibodies (Invitrogen) for 90 min at RT in dilution buffer. After extensive washes in PBS with 0.25% Triton X-100, sections were mounted on gelatin-coated slides, dried, and mounted in Mowiol-DABCO. Fluorescence was analyzed on a Zeiss 510 Meta confocal microscope (Zeiss Microimaging) at 20ϫ and 40ϫ magnification. Images were adjusted for overall brightness and contrast in Adobe Photoshop (Adobe Systems).
Behavioral testing battery
Cohorts. Only male mice were used for behavioral testing. Prepulse inhibition of the startle response. The SR-Lab Startle Response System (San Diego Instruments) was used to measure PPI. Mice were placed in a clear Plexiglas holding cylinder and, after 5 min acclimation, presented with random trials of startle (40 ms at an intensity of 120 dB), prepulse ϩ startle (20 ms of 3, 6, 12, and 17 dB above background noise followed, 100 ms later, by 40 ms at an intensity of 120 dB) and nonstartling-stimulus (NSS). A 65 dB background sound was presented throughout the session. Intertrial intervals averaged 15 s (range: 5-20 s). Percentage PPI was calculated as [(startle response Ϫ NSS) Ϫ (prepulse ϩ startle response Ϫ NSS)/(startle response Ϫ NSS)] * 100.
Elevated plus maze. A Plexiglas plus-shaped maze containing two dark enclosed arms and two open lit arms elevated 50 cm above ground was used to examine anxiety-related behaviors. The arms were 30 ϫ 5 cm with a 5 ϫ 5 cm center area, and the walls of the closed arms were 20 cm high. Trials were started by placing mice in the center of the maze. Mice were tracked for 5 min with a video camera, and then returned to their home cage. The plus maze was wiped clean between trials with a 70% alcohol solution. Time spent in the maze and frequency of visits to different zones of the maze was scored using Any Maze program (Stoelting).
Contextual and cued fear conditioning. Mice were trained and tested for fear conditioning using the San Diego Instruments Freeze Monitor. Freezing, defined as the lack of all movement other than respiration, was used as the measure of conditioned fear. Freezing was scored using the Freeze Detector System (San Diego Instruments), an automatic freezing scoring program. During training, mice were placed in the chamber and exposed to two conditioned (CS; 85 dB white noise, 30 s) and unconditioned (US; 0.5 mA foot shock, 2.0 s) stimulus. The CS-US stimuli were paired and separated by a 120 s intertrial interval. Following the last CS-US stimulus, the training session ended with a 3 min period during which freezing behavior was recorded. Contextual fear conditioning testing was performed 24 h after training. Mice were returned to the training chambers and freezing was scored for 5 min. Twenty-four hours later, mice were placed in an altered context to test for generalized freezing and for cued fear conditioning. For generalized freezing, freezing behavior was scored for 2 min before the CS and for cued fear conditioning 3 min after the CS.
Resident intruder test. ErbB4 mutants and their WT control cohorts were single-housed 1 week before testing. A C57BL/6J male mouse was introduced into the home cage of the tested mouse. Their activities were videotaped for 10 min and scored for time spent on olfactory investigations (sniffing), and for the number of side approaches, tail rattlings, and attack bitings.
Saccharin preference test. Hedonic-like behavior was measured using the saccharin preference test. Mice were single-housed for 1 week and then tested for their preference for saccharin in their home cage. Mice were given access for 2 d to two 2 drinking bottles containing tap water. On day 3, one of the water bottles was replaced with a bottle containing 0.01% saccharin solution, and the consumption of water and saccharin was measured for 2 consecutive days. The position of the bottles was changed daily to prevent side preference.
Results
NRG-1␤ inhibits LTP induction elicited by a pairing protocol
LTP can be broadly separated into induction and expression phases. At SC3 CA1 glutamatergic synapses, LTP induction depends on NMDA receptor activation and expression manifests as an increase in synaptic AMPA receptor currents. We previously demonstrated that a recombinant protein encompassing the EGF domain of NRG-1␤ 1 (hereafter referred to as NRG-1␤), added 20 min after LTP induction, reverses expression of LTP elicited by theta-burst stimulation or pairing by reducing AMPAR currents to preinduction levels (Kwon et al., 2005 (Kwon et al., , 2008 . To analyze the effects of NRG-1␤ on LTP induction using a pairing protocol, we perfused hippocampal slices with 1 nM NRG-1␤ 15 min before pairing for a total of 10 min. Of note, NRG-1␤ had no effect on baseline EPSCs in the absence of LTP-inducing stimuli, as shown previously (Kwon et al., 2005) . As illustrated in Figure 1 , pairing failed to induce LTP in NRG-1␤ pretreated slices (Ϫ10 -0 min: 95 Ϯ 14%; 40 -50 min: 105 Ϯ 19%), while untreated control slices exhibited robust LTP (188 Ϯ 15%; p Ͻ 0.01 for the comparison between controls and NRG-1␤ at 40 -50 min after pairing). NRG-1␤ did not block LTP induction when slices were pretreated with the pan-ErbB receptor kinase inhibitor PD158780 (10 M). Moreover, compared with untreated controls, a small but significant enhancement of LTP was observed, suggesting that inhibition of endogenous NRG/ErbB signaling by PD158780 augments LTP (229 Ϯ 9% vs 188 Ϯ 15%; p Ͻ 0.01).
LTP is enhanced in full and PV interneuron-restricted ErbB4 mutant as well as NRG-1 hypomorphic mice
ErbB4 is the major neuregulin receptor in CNS neurons, and pharmacological ErbB receptor blockade by PD158780 blocks LTP reversal by NRG-1␤ and neural activity (Kwon et al., 2005) . However, direct genetic evidence implicating ErbB4 in LTP reversal at SC3 CA1 synapses has been lacking. We therefore began by comparing LTP in slices from wild-type and ErbB4 MHCErbB4 mice harboring a mutant Erbb4 gene in all cells. These mice, hereafter referred to as ErbB4 Ϫ/Ϫ , are rescued from embryonic lethality by transgenic expression of ErbB4 in the heart (Tidcombe et al., 2003) . As shown in Figure 2 A, LTP was significantly enhanced in mutants compared with control wild-types (ErbB4 Ϫ/Ϫ : 260 Ϯ 17% vs WT: 181 Ϯ 12%, p Ͻ 0.001), consistent with the acute effects of ErbB receptor blockade by PD158780 on LTP in wild-type mice. These findings support the notion that NRG/ErbB4 signaling in the hippocampus serves as a counterbalance to the effects of potentiating stimuli. We also measured LTP in ErbB4 heterozygous mice and found that it was moderately enhanced as well (ErbB4 Ϫ/ϩ : 214 Ϯ 27%; Fig. 2 B) . The magnitude of LTP was between those observed in wild-type and ErbB4 Ϫ/Ϫ mice, and mean EPSC amplitudes between 40 and 50 min after pairing were significantly different from both ( p Ͻ 0.001 for both comparisons), indicating that ErbB4 dosedependently antagonizes LTP.
We next investigated the specific role of ErbB4 signaling in PV interneurons for hippocampal plasticity. PV-Cre;ErbB4 mice, obtained by crossing mice harboring a conditional ErbB4 allele with mice expressing Cre recombinase from the PV locus, show strongly reduced ErbB4 protein levels in extracts from the frontal cortex and hippocampus (Fig. 2C, top) . This is consistent with the extensive coexpression of ErbB4 in PV interneurons in both areas (Neddens and Buonanno, 2010) . Residual signals observed in extracts from PV-Cre;ErbB4 mice likely represent ErbB4 expression by other GABAergic interneurons that also coexpress ErbB4. To ascertain the faithfulness of PVCre-mediated ErbB4 ablation, we colabeled sections from the frontal cortex where virtually all PV interneurons coexpress ErbB4 (Neddens et al., 2011) . As shown in Figure  2C (bottom), while we frequently observed ErbB4-IR in PV interneurons from control sections from ErbB4 f/f mice, we were unable to find ErbB4-IR in PV interneurons from PV-Cre;ErbB4 mice. Occasional ErbB4-IR cells were immunonegative for PV and likely represented other types of GABAergic interneurons. Similar results were obtained in the hippocampus (data not shown). We then proceeded to measure LTP in PV-Cre; ErbB4 mice. Consistent with the notion that ErbB4 signaling in PV interneurons plays an important role in mediating the effects of NRG-1 on hippocampal plasticity, we found that normalized mean EPSC amplitudes were significantly increased in PVCre;ErbB4 mice compared with their control ErbB4 f/f littermates (PV-Cre;ErbB4: 322 Ϯ 43% vs ErbB4
The acute effects of NRG-1 on LTP have been studied by perfusing hippocampal slices with exogenous NRG-1␤ peptide (Fig. 1) . To investigate the role of endogenous NRG-1, which is expressed in CA3 pyramidal neurons (Law et al., 2004; Longart et al., 2004) , we compared LTP between wild-type mice and heterozygous NRG-1 mutant mice with targeted deletions of exons encoding the EGF-like domain; NRG-1-null mice die at E9.5 and could therefore not be used. As in the case of ErbB4 mutant and hypomorphic mice, NRG-1 heterozygous mice exhibited enhanced LTP (NRG-1 ϩ/Ϫ : 258 Ϯ 14% vs WT: 166 Ϯ 28%, p Ͻ 0.001; Fig. 2 E) . However, we noticed a somewhat different time course following LTP induction, with an apparent extended period of strongly enhanced LTP immediately after pairing, followed by a phase marked by decreasing LTP levels and eventual stabilization at intermediate levels that were remarkably similar to LTP in ErbB4-null mice (mean relative EPSC amplitudes: 306 Ϯ 23% at 0 -20 min vs 259 Ϯ 16% at 40 -60 min, p Ͻ 0.001). While these findings might suggest additional effects of NRG-1 hemizygosity on synaptic plasticity at SC3 CA1 synapses, they are nevertheless consistent with the notion that genetic perturbations of both the ligand and the receptor result in similar outcomes and support the idea that endogenous NRG-1/ ErbB4 signaling acts as a counterbalance to LTP-promoting processes.
LTP reversal by NRG-1␤ or TPS is absent in ErbB4
؊/؊ mice In wild-type controls, 1 nM NRG-1␤, perfused 20 min after pairing for a total of 10 min, rapidly reverted LTP back to baseline levels (Fig. 3A) . By contrast, slices from ErbB4-null mice were resistant to the acute effects of exogenously added NRG-1␤ (ErbB4 Ϫ/Ϫ : 220 Ϯ 16% vs WT: 104 Ϯ 18%, p Ͻ 0.001), demonstrating the critical requirement of ErbB4 for NRG-1␤-mediated LTP reversal. LTP can also be reversed by TPS (5 Hz, 1 min) if delivered shortly after LTP induction. TPS are modeled after normal hippocampal activity patterns observed during exploratory activity, and therefore represent a possible endogenous pathway for LTP reversal (Stäubli and Chun, 1996) . We have previously shown that TPSmediated LTP reversal is absent when slices are pretreated with the ErbB receptor inhibitor PD158780 (Kwon et al., 2005) , implicating NRG/ErbB signaling in mediating the effects of TPS on early phase hippocampal LTP. As shown in Figure 3B , application of TPS 5 min after LTP induction by pairing is ineffective in slices from ErbB4 Ϫ/Ϫ mice whereas they completely reverse LTP in slices from wildtype mice (ErbB4 Ϫ/Ϫ : 199 Ϯ 15% vs WT: 107 Ϯ 15% of baseline, 40 -50 min after LTP induction). Likewise, TPS were also without effect in PV-Cre;ErbB4 mice (PVCre;ErbB4: 261 Ϯ 3% vs ErbB4 f/f : 121 Ϯ 3%; p Ͻ 0.002; Fig. 3C ). Together, these data firmly establish ErbB4 as a critical mediator of the inhibitory effects of NRG-1 and TPS on earlyphase LTP, and furthermore reveal PV interneurons as the primary locus of ErbB4 signaling underlying LTP reversal.
It is reasonable to assume that TPS might trigger LTP reversal by somehow promoting the release of endogenous NRG to activate ErbB4. We reasoned, therefore, that TPS in NRG-1 heterozygous mice might be less effective than in WT mice. Consistent with this idea, Figure 3C shows that unlike in WT slices, EPSC amplitudes in slices from NRG-1 heterozygous mice remained elevated after TPS and only slowly ran down (10 -20 min: 164 Ϯ 46% vs 30 -40 min: 137 Ϯ 41%; p Ͻ 0.01) to stabilize at levels that continued to be moderately potentiated (average EPSC amplitudes 30 -60 min after pairing: NRG-1 ϩ/Ϫ : 134 Ϯ 40% vs WT: 111 Ϯ 21%; p Ͻ 0.001). These data are consistent with the idea that reduced levels of NRG-1 in NRG-1 ϩ/Ϫ mice are only partly effective to stimulate ErbB4 signaling in response to TPS.
Behavioral analysis of full and PV-interneuron selective ErbB4 mutant mice
A recent study reported some behavioral abnormalities in mice in which the Erbb4 gene was conditionally ablated using Cre expressed under the control of the PV promoter . Since a comprehensive behavioral analysis has not been performed for mice lacking ErbB4 in all neurons, we sought to compare cohorts of ErbB4 Ϫ/Ϫ and PV-Cre;ErbB4 mice with their respective wild-type littermate controls in a battery of tests designed to investigate rodent behaviors potentially pertinent for behavioral abnormalities found in individuals with schizophrenia and other psychiatric disorders. The battery of tests performed on these cohorts included open field, PPI of acoustic startle, elevated plus maze, fear conditioning, as well as saccharin preference and resident intruder tests. Because the ErbB4 Ϫ/Ϫ cohort exhibited no alterations in the saccharin preference test (a paradigm used for the assessment of hedonic behavior) or the resident intruder test for aggressive behavior, we did not subject the PV-Cre;ErbB4 cohort to these tests.
Open field test
Spontaneous locomotor activity in response to novelty is widely used to model positive symptoms of schizophrenia. In the open field test, both ErbB4 Ϫ/Ϫ and PV-Cre;ErbB4 cohorts exhibited significantly more locomotor activity than their respective normal littermate control groups (Fig. 4) . This hyperactivity was apparent at all times during the 30 min observations. Full ErbB4 knock-out mice traveled a total distance of 6900 Ϯ 550 cm, compared with 4600 Ϯ 460 cm in the control group (n ϭ 17 for both groups; p Ͻ 0.05, Student's t test). Similarly, PV-Cre;ErbB4 mice traveled a total distance of 6000 Ϯ 480 cm compared with their littermate control group that traveled 4500 Ϯ 420 cm ( p Ͻ 0.05, Student's t test). Although the observed differences in total distance traveled between the full and PV interneuron-restricted Erbb4-null mice were suggestive of an effect of genotype, differences in strain backgrounds between these two mutants precluded a direct comparison. Notwithstanding, the finding that both strains of ErbB4 mutant mice were hyperactive strongly suggests that ErbB4 signaling in PV interneurons contributes substantially to the regulation of novelty-induced locomotor activity.
PPI of the startle response
PPI is a widely used measure of sensorimotor gating in rodents and humans (Geyer, 2008) , and deficits in this task have been reproducibly found in individuals with schizophrenia (Braff, 2010) . Figure 5 shows that, like in the open field test, both ErbB4 mutants exhibited deficits in PPI. Two-way ANOVA with repeated measurements detected significant effects of genotype ( p Ͻ 0.01) and genotype ϫ prepulse sound level ( p Ͻ 0.05). Post hoc analysis revealed that reductions in PPI levels were more pronounced at lower prepulse sound levels (68 dB: 6 Ϯ 2% and 23 Ϯ 5% for ErbB4 Ϫ/Ϫ vs controls, p Ͻ 0.05; 15 Ϯ 5% and 32 Ϯ 5% for PV-Cre;ErbB4 vs controls; p Ͻ 0.01) than at higher prepulse sound levels (77 dB: 58 Ϯ 8% and 80 Ϯ 2% for ErbB4 Ϫ/Ϫ vs controls, p Ͻ 0.05; 65 Ϯ 7% vs 86 Ϯ 2% for PV-Cre;ErbB4 vs controls; p Ͻ 0.05). At 82 dB, PPI was not significantly different between both ErbB4 mutant strains and their respective controls (94 Ϯ 1% and 89 Ϯ 3% for controls vs ErbB4 Ϫ/Ϫ , p ϭ 0.11; 89 Ϯ 1% and 81 Ϯ 5% for controls vs PV-Cre;ErbB4; p ϭ 0.14). These data indicate that PPI deficits are more pronounced at smaller differentials between the prepulse and background sound levels (68 dB: ⌬3 dB; 82 dB: ⌬17 dB). Importantly, acoustic startle responses, per se, were not significantly different between mutants and their respective controls, affirming that all pertinent sensorimotor functions were unaffected (data not shown).
Elevated plus-shaped maze
To evaluate possible alterations in fear and anxiety-related behaviors in ErbB4 mutant mice, we tested their performance in the elevated plus maze. As shown in Figure 6 Ϫ/Ϫ (gray triangles) and its littermate control group (Con, black diamonds) (A) and for PV-Cre;ErbB4 mice (gray squares) and its respective littermate controls (Con, black diamonds) (B). Data points represent 5 min bins of locomotor activity. N ϭ 17 for ErbB4 Ϫ/Ϫ and its control group; N ϭ 8 for PV-Cre;ErbB4 and 11 for its control group.
often as their wild-type controls (on average, 13.9 vs 6.9 visits) and also visited the closed arms approximately twice as often (18.3 vs 10.4 visits). The increased overall activity of ErbB4 Ϫ/Ϫ mice in the elevated plus-shaped maze, as assessed by the increase in the number of entries into either arm, is generally considered a built-in control measure for general activity, and therefore consistent with the corresponding data from the open field test. Together, these results suggest reduced anxiety in ErbB4-null mice. However, unlike in the open field and PPI tests, defective ErbB4 signaling in PV interneurons apparently does not account for the effects observed in full ErbB4 Ϫ/Ϫ mice.
Cued and contextual fear conditioning
To more directly assess the role of ErbB4 in fear-related behaviors, and to reveal possible differences between full and PVinterneuron selective ErbB4 mutants, we tested our cohorts in cued and contextual fear conditioning. Cued fear conditioning is generally believed to be largely dependent on the amygdala, while contextual fear conditioning involves both the amygdala and the hippocampus (Phillips and LeDoux, 1992) . Interestingly, before and during the two training trials, freezing levels were consistently lower for ErbB4 Ϫ/Ϫ mice compared with controls (naive, 3% vs 10%; first trial, 8% vs 21%; second trial, 21.2% and 33.5%; F (2,42) ϭ 7.04; p Ͻ 0.05, two-way ANOVA). However, no interaction between genotype and trial was found (F (2,42) ϭ 0.23; p ϭ 0.80, two-way ANOVA), suggesting that the difference in freezing between WT and mutant mice is not related to training, i.e., the ability of ErbB4 Ϫ/Ϫ mice to acquire conditioned fear. Unlike full ErbB4 mutant mice, PV-Cre;ErbB4 mice and their controls performed similarly during training. As shown in Figure  7 , in the testing phase, ErbB4 Ϫ/Ϫ mice exhibited significantly lower freezing responses when presented with the conditioned stimulus in a completely new context, as well as when returned to the training environment (cue: 59 Ϯ 6% for controls vs 28 Ϯ 4% for ErbB4 Ϫ/Ϫ , p Ͻ 0.01; context: 40 Ϯ 7% for controls vs 20 Ϯ 4% for ErbB4 Ϫ/Ϫ , p Ͻ 0.05; Student's t test). In stark contrast, neither cued nor contextual fear conditioning was different between the PV-Cre;ErbB4 group and their controls (cue: 50 Ϯ 4% for controls vs 57 Ϯ 6% for PV-Cre;ErbB4, p ϭ 0.31; context: 24 Ϯ 7% for controls vs 33 Ϯ 6% for PV-Cre;ErbB4, p ϭ 0.39; Student's t test). Together, the results from the elevated plus maze and fear conditioning tests suggest that the NRG/ErbB4 signaling pathway affects neural circuits involved in the regulation of anxiety and fear-related behaviors, but that ErbB4 effects on PV interneurons play a minor role in these processes.
ErbB4 and PV expression is mostly non-overlapping in the amygdala
To further substantiate the notion that ErbB4 deficiency in PV interneurons is unlikely to contribute to altered amygdalar function observed in full ErbB4 mutants, we analyzed expression of ErbB4 and PV in the amygdala. PV mRNA expression is generally sparse in basolateral (BLA) and basomedial (BMA) areas, two of the major amygdalar nuclei (Fig. 8 ) (Allen Mouse Brain Atlas, 2009) . By comparison, ErbB4 mRNA signal density in the BLA is moderately higher and is extraordinarily high in the BMA. We used immunofluorescence histology to determine the extent of coexpression of PV and ErbB4. To unambiguously identify ErbB4-and PV-expressing cell bodies, we resorted to a mouse line in which tamoxifen-inducible Cre recombinase expressed from the Erbb4 locus and translated from a fusion transcript between ErbB4 and Cre drives the recombination and subsequent high-level expression of tdTomato fluorescent protein from the Rosa26 locus (Erbb4-2A-CreERT2). This mouse has been shown to faithfully report the expression pattern of ErbB4 (Madisen et al., 2010) . As shown in Figure 8 , the general pattern of cell bodies expressing ErbB4 mRNA and tdTomato following Cre-mediated recombination was very similar, with high densities of fluorescent cell bodies in the BMA, and a much sparser distribution in the BLA. Strikingly, the overlay between tdTomato and PV demonstrates that, while some colocalization was observed in the BLA where both ErbB4 and PV are sparse, virtually all tdTomato expression in the BMA was in cells immunonegative for PV. We conclude that the majority of ErbB4-expressing cells in the amygdala are not PV interneurons. This finding provides a rational basis for the observed differences in fear-related behaviors between full and PV-restricted ErbB4 mutant mice.
Discussion
The major findings of this study are as follows: (1) ErbB4 Ϫ/Ϫ , PV-Cre;ErbB4, and NRG-1 hypomorphic mice all show enhanced hippocampal LTP; (2) ErbB4 mediates the effects of NRG-1 and TPS on LTP reversal; (3) ErbB4 signaling in PV interneurons is critical to reverse LTP by neuronal stimuli; and (4) ErbB4 Ϫ/Ϫ mice exhibit numerous behavioral deficits, some of which they share with, and others that are not reproduced by, PV-Cre;ErbB4 mice. Our findings firmly establish NRG/ErbB4 signaling in PV interneurons as an important counterbalance to processes promoting hippocampal LTP, and as a powerful modulator of behaviors relevant to schizophrenia and other psychiatric disorders. Intriguingly, deficits in synaptic plasticity have been postulated to contribute to functional dysconnectivity in schizophrenia Kwon et al., 2005) . Because of the interneuron-restricted expression of ErbB4 in the hippocampus and the finding that selective ablation of Erbb4 in pyramidal neurons does not affect NRG-1-mediated inhibition of LTP induction , the most parsimonious scenario still places the first events leading up to LTP inhibition or reversal on ErbB4-expressing PVinterneurons. Based on our previous findings that NRG-1 acutely triggers dopamine release in the dorsal hippocampus, and that LTP reversal by NRG-1 and TPS critically depends on the activation of dopamine D4 receptors (Kwon et al., 2008) , we propose that NRG/ErbB4 signaling in PV interneurons engages this dopaminergic signaling pathway to regulate synaptic plasticity; a direct effect of NRG on dopaminergic terminals cannot presently be excluded. Future studies will be necessary to work out the mechanism by which this occurs.
ErbB4 and behavior
Based on the intricate expression pattern of ErbB4 during development and in the adult brain, we decided to compare the behavioral outcomes between ErbB4 Ϫ/Ϫ and PV-Cre;ErbB4 mice. Interest in identifying the potential role of PV-expressing interneurons in mediating NRG/ErbB4 effects on behavior stems from multiple observations, including (1) the extensive coexpression of PV and ErbB4 in the PFC and, albeit to a lesser extent, the hippocampus (Fisahn et al., 2009; Fazzari et al., 2010; Neddens and Buonanno, 2010) ; (2) the notion that PV interneurons are involved in gamma oscillations whose power is reduced in schizophrenia (Kwon et al., 1999; Wilson et al., 2008) ; and (3) the finding that the number of PV mRNA and protein-expressing cells is reduced in the PFC of individuals with schizophrenia (for review, see Lewis et al., 2005) . Intriguingly, acute NRG-1/ErbB4 signaling potently augments the power of kainateinduced hippocampal gamma oscillations, while slices from ErbB4 Ϫ/Ϫ mice exhibit reduced gamma power. Moreover, the number of PV interneurons is reduced by 31% in the hippocampus of ErbB4 Ϫ/Ϫ mice (Fisahn et al., 2009 ). Our study represents the first comprehensive behavioral analysis of mice lacking ErbB4 in all cells except the heart. Only one study investigated the effects of selectively ablating Erbb4 throughout the CNS by crossing floxed Erbb4 with Nestin-Cre mice (Golub et al., 2004) . The authors interestingly observed that adult mutant mice were hypoactive in a novel environment. A second study, using hGFAP-Cre to ablate both Erbb2 and Erbb4 genes in the CNS, found no difference in horizontal activity, but interpretation of this finding is complicated by the fact that removal of Erbb2 is also expected to affect signaling via ErbB3 and EGF receptors (Barros et al., 2009 ). In contrast, we (this work) and others have shown that ErbB4 Ϫ/Ϫ and PV-Cre;ErbB4 mice are hyperactive in the open field test. To what extent these seemingly disparate findings represent differences in gene targeting strategies (i.e., unconditional vs floxed alleles), strain backgrounds, or other methodological details, is currently not understood. Nevertheless, the increasing evidence for a role of the NRG-1/ErbB4 pathway in regulating dopaminergic function (for review, see Buonanno, 2010) , together with data indicating that NRG-1 hypomorphic mice are also hyperactive (Gerlai et al., 2000; Stefansson et al., 2002; Duffy et al., 2008; O'Tuathaigh et al., 2010) and that activity in the open field is a good indicator of nigrostriatal dopaminergic state, provides a possible neurochemical link between ErbB4 and spontaneous locomotor activity.
Deficits in sensorimotor gating have been observed in all ErbB4 mutant mouse strains thus far tested in PPI, including full, PVrestricted, and double Erbb2/Erbb4 mutant mice (Chen et al., 2008; Barros et al., 2009 ; this work). Moreover, some studies showed reduced PPI in different NRG-1 hypomorphic mouse strains targeting all isoforms (⌬EGF) or specific subsets of NRG-1 variants (for review, see van den Buuse, 2010) , in particular of NRG-1 type III, the predominating NRG-1 isoform in the adult brain (Chen et al., 2008) . In aggregate, these findings attest to the significant contribution of the NRG/ErbB4 signaling pathway to neural processes underlying normal gating responses. PPI deficits are widely regarded endophenotypic for schizophrenia and PPI is sensitive to treatments generating hyperdopaminergic and hypoglutamatergic states (Braff, 2010; van den Buuse, 2010) . The finding that PV interneuron-restricted ErbB4 mutant mice replicate the hyperactivity and sensorimotorgating phenotypes of full ErbB4 Ϫ/Ϫ mice emphasizes the significant contribution of the NRG-1/ErbB4 pathway for normal function of PV interneurons.
While both ErbB4 Ϫ/Ϫ and PV-Cre;ErbB4 mice shared hyperactivity and PPI deficits, a divergent phenotypic outcome was observed in behavioral tasks assessing anxiety and fear. While Erbb4 Ϫ/ Ϫ mice exhibited deficits in the elevated plus maze and in cued and contextual fear conditioning, PV-Cre;ErbB4 mice were not different from their control littermates in these tasks. Only one other study investigated the effects of genetically ablating ErbB4 signaling on emotional learning and reported reduced contextual fear conditioning in mice with targeted ErbB4 mutations in PV interneurons, a finding that was interpreted as indicative of abnormal LTP regulation in the hippocampus of these mice . While we presently cannot satisfactorily explain the discrepancy between our groups, the fact that we observed deficits in both cued and contextual fear conditioning in ErbB4 Ϫ/Ϫ mice, together with the widespread expression of ErbB4 in the amygdala, in particular in the BMA, is consistent with the notion that NRG/ErbB4 signaling in the amygdala is important for emotional learning. The lack of such deficits in PV-Cre;ErbB4 mutant mice is consistent with the relatively sparse distribution of PV interneurons in the amygdala and our finding that most ErbB4-expressing neurons in the amygdala do not coexpress PV. More refined histological analyses of ErbB4 expression in the amygdala and Erbb4 targeting strategies will be required to identify the pertinent neuron types and signaling processes involved in NRG/ErbB4-mediated regulation of fear behavior.
